+44 (0)24 7671 8970
More publications     •     Advertise with us     •     Contact us
 
Loading...
News Article

On-chip optical tweezers combat antibiotic resistance

News

Scientists say the “nanotweezers” allow scientists to precisely trap and study individual bacteria, potentially providing a powerful new research tool in microbiology

With antibiotic resistance looming as a formidable threat to our health, scientists are on a constant quest for alternative ways to treat bacterial infections. As more and more bacterial strains outsmart drugs we have been relying on for decades, a possible alternative solution may be found in bacteriophages, which are viruses that prey on bacteria.

Phage therapy, the use of bacteriophages to combat bacterial infections, is gaining attraction as a viable alternative to traditional antibiotics. But there is a catch: finding the right phage for a given infection is like searching for a needle in a haystack, while current methods involve cumbersome culturing, time-consuming assays.

Now, scientists at EPFL, in collaboration with the CEA Grenoble and the Lausanne University Hospital (CHUV) have developed on-chip “nanotweezers” that can trap and manipulate individual bacteria and virions (the infectious form of a virus) using a minimal amount of optical power. The study, led by Nicolas Villa and Enrico Tartari in the group of Romuald Houdré at EPFL, is published in the journal Small.

The nanotweezers are a type of “optical tweezers”, scientific instruments that use a highly focused laser beam to hold and manipulate microscopic objects, such as virions, and even sub-microscopic objects like atoms in three dimensions. The light creates a gradient force that attracts the particles towards a high-intensity focal point, effectively “holding” them in place without physical contact.

Optical tweezers were first invented in 1986 by the physicist Arthur Ashkin who worked out the principles behind them in the late 1960s. Ashkin’s technological innovation won him the 2018 Nobel Prize in Physics, and optical tweezers remain an intense field of research.

There are different types of optical tweezers. For example, free-space optical tweezers can manipulate an object in an open environment such as air or liquid without any without any physical barriers or structures guiding the light. But in this study, the researchers built nanotweezers embedded in an optofluidic device that integrates optical and fluidic technologies on a single chip.

The chip contains silicon-based photonic crystal cavities — the nanotweezers, which are essentially tiny traps that gently nudge the phages into position using a light-generated force field. The system allowed the researchers to precisely control single bacteria and single virions and acquire information about the trapped microorganisms in real time.

What sets this approach apart is that it can distinguish between different types of phages without using any chemical labels or surface bioreceptors, which can be time-consuming and sometimes ineffective. Instead, the nanotweezers distinguish between phages by “reading” the unique changes each particle causes in the light’s properties. The label-free method can significantly accelerate the selection of therapeutic phages, promising faster turnaround for potential phage-based treatments.

The research also has implications beyond phage therapy. Being able to manipulate and study single virions in real time opens up new avenues in microbiological research, offering scientists a powerful tool for rapid testing and experimentation. This could lead to a deeper understanding of viruses and their interactions with hosts, which is invaluable in the ongoing battle against infectious diseases.

Image credit: EPFL

Samco Inc announces sale of etching systems to III-V Lab
European Innovation Council funds QuiX Quantum
Intel and Source Photonics partner on 800G transceivers
LioniX secures €1.5 million in bridge financing
A technique for 3D nanostructuring inside silicon
Senergetics wins Gerard and Anton Award
Scantinel announces new CMOS-based LiDAR chip
Project to miniaturise spectrograph wins €3.4 million
EU invests €325 million in Europe's semiconductor ecosystem
Fraunhofer IPMS developing near-infrared silicon-based photodiodes
PhotonDelta opens US office in Silicon Valley
EU funds integrated photonics for space navigation
Maryland Department of Commerce funds PIC testing and packaging facility
Lightmatter appoints Simona Jankowski as chief financial officer
scia Systems to showcase ion beam processing advances at SEMICON West
Quantifi Photonics announces Iannick Monfils as new CEO
Nokia and TTI achieve 800G on long-haul commercial network
Nokia to acquire Infinera for $2.3 billion
Advancing AI with programmable silicon photonics
Quantum PICs: Empowering designers with accurate simulations
Enabling efficient light emission and detection
Harnessing InP for applications beyond optical communications
POET wins “Best Optical AI Solution” in AI Breakthrough Awards
Intel reveals fully integrated optical I/O chiplet
People, planet, profits: a sustainable way forward for all
A bright future for the global PIC market
Atom-thin silicon-germanium sheets for integrated photonics
BAE Systems and GlobalFoundries partner on semiconductors
Wave Photonics raises £4.5 million in seed funding
Aeva to supply LiDAR for AutomatedTrain project in Germany
Black Semiconductor raises €254.4 million for graphene chips
Pooya Tadayon joins Ayar Labs

×
Search the news archive

To close this popup you can press escape or click the close icon.
Logo
×
  • 1st January 1970
  • 1st January 1970
  • 1st January 1970
  • 1st January 1970
  • 1st January 1970
  • 1st January 1970
  • 1st January 1970
  • 1st January 1970
  • View all news 22645 more articles
Logo
×
Register - Step 1

You may choose to subscribe to the PIC Magazine, the PIC Newsletter, or both. You may also request additional information if required, before submitting your application.


Please subscribe me to:

 

You chose the industry type of "Other"

Please enter the industry that you work in:
Please enter the industry that you work in: